Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 47121 

• No fewer than 2 members are 

advocates for patients or consumers of 

health information technology; 

• 3 members are appointed by the 

HHS Secretary 

Æ 1 of whom shall be appointed to 

represent the Department of Health and 

Human Services and 

Æ 1 of whom shall be a public health 

official; 

• 2 members are appointed by the 

majority leader of the Senate; 

• 2 members are appointed by the 

minority leader of the Senate; 

• 2 members are appointed by the 

Speaker of the House of Representatives; 

• 2 members are appointed by the 

minority leader of the House of 

Representatives; and 

• Other members are appointed by 

the Comptroller General of the United 

States. 

Members will serve for one-, two-, or 

three-year terms. All members may be 

reappointed for a subsequent three-year 

term. Each member is limited to two 

three-year terms, not to exceed six years 

of service. Members serve without pay, 

but will be provided per-diem and 

travel costs for committee services, if 

warranted. 

Recommendations 

The HITAC recommendations to the 

National Coordinator are publicly 

available at https://www.healthit.gov/ 

topic/federal-advisory-committees/ 

recommendations-national-coordinatorhealth-it. 

Public Meetings 

The schedule of meetings to be held 

in 2021 is as follows: 

• January 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• February 10, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• March 10, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• April 15, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• May 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• June 9, 2021 from approximately 9:30 

a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• July 14, 2021 from approximately 9:30 

a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• September 9, 2021 from 

approximately 9:30 a.m. to 2:30 p.m./ 

Eastern Time (virtual meeting) 

• October 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• November 10, 2021 from 

approximately 9:30 a.m. to 2:30 p.m./ 

Eastern Time (virtual meeting) 

All meetings are open to the public. 

Additional meetings may be scheduled 

as needed. For web conference 

instructions and the most up-to-date 

information, please visit the HITAC 

calendar on the ONC website, https://

www.healthit.gov/topic/federaladvisory-committees/hitac-calendar. 

Contact Person for Meetings: Michael 

Berry, Michael.Berry@hhs.gov. A notice 

in the Federal Register about last 

minute modifications that impact a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. Please email Michael 

Berry for the most current information 

about meetings. 

Agenda: As outlined in the 21st 

Century Cures Act, the HITAC will 

develop and submit recommendations 

to the National Coordinator on the 

topics of interoperability, privacy and 

security, and patient access. In addition, 

the committee will also address any 

administrative matters and hear 

periodic reports from ONC. ONC 

intends to make background material 

available to the public no later than 24 

hours prior to the meeting start time. If 

ONC is unable to post the background 

material on its website prior to the 

meeting, the material will be made 

publicly available on ONC’s website 

after the meeting, at http://

www.healthit.gov/hitac. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person prior to the meeting date. An 

oral public comment period will be 

scheduled at each meeting. Time 

allotted for each commenter will be 

limited to three minutes. If the number 

of speakers requesting to comment is 

greater than can be reasonably 

accommodated during the scheduled 

public comment period, ONC will take 

written comments after the meeting. 

Persons attending in-person HITAC 

meetings are advised that the agency is 

not responsible for providing wireless 

access or access to electrical outlets. 

ONC welcomes the attendance of the 

public at its HITAC meetings. Seating is 

limited at in-person meetings, and ONC 

will make every effort to accommodate 

persons with physical disabilities or 

special needs. If you require special 

accommodations due to a disability, 

please contact Michael Berry at least 

seven (7) days in advance of the 

meeting. 

Notice of these meetings are given 

under the Federal Advisory Committee 

Act (Pub. L. No. 92–463, 5 U.S.C., App. 

2). 

Dated: July 27, 2021. 

Michael Berry, 

Designated Federal Officer, Office of the 

National Coordinator for Health Information 

Technology. 

[FR Doc. 2021–18019 Filed 8–20–21; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIGMS Review of SuRE Applications. 

Date: November 18, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Sonia Ortiz-Miranda, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3AN18, 

Bethesda, MD 20892, (301) 402–9448, 

sonia.ortiz-miranda@nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIGMS Review of SuRE Applications. 

Date: November 19, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Manas Chattopadhyay, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, Building 45, Room 3AN12N, 45 

Center Drive, Bethesda, MD 20892, 301–827– 

5320, manasc@mail.nih.gov. 


jbell on DSKJLSW7X2PROD with NOTICES
47122 Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: August 18, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18047 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: September 14, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Soheyla Saadi, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3E70A, Rockville, MD 

20852, (240) 669–5178, saadisoh@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 17, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17988 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Fellowships in 

Digestive Diseases and Nutrition. 

Date: October 14–15, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Diabetes and 

Digestive and Kidney Diseases, NIH, 6707 

Democracy Boulevard, Room 7011, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, Review Branch, Division of 

Extramural Activities, NIDDK, NIH, Room 

7011, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7799, yangj@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 18, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18040 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging, Initial Review Group; Career 

Development for Established Investigators 

and Conference Grants Study Section NIA– 

AGCD–4. 

Date: October 14, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, 301–402–1622, bissonettegb@

mail.nih.gov. 

Name of Committee: National Institute on 

Aging, Initial Review Group; Career 

Development for Early Career Investigators 

Study Section NIA–AGCD–2. 

Date: October 14–15, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Carmen Moten, Ph.D., 

MPH Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway Bldg., 

2C212, 7201 Wisconsin Avenue, Bethesda, 

MD 20814, 301–402–7703, cmoten@

mail.nih.gov. 

Name of Committee: National Institute on 

Aging, Initial Review Group; Career 

Development Facilitating The Transition to 

Independence Study Section NIA–AGCD–1. 

Date: October 14–15, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 


jbell on DSKJLSW7X2PROD with NOTICES